Acceptability of a first-line anti-tuberculosis formulation for children: qualitative data from the SHINE trial. (2019)

First Author: Wademan DT

Attributed to: MICA: randomized trial of therapy shortening for minimal TB with new WHO-recommended doses and FDC drugs in African/Indian HIV+/HIV- children funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.5588/ijtld.19.0115

PubMed Identifier: 31931909

Publication URI: http://europepmc.org/abstract/MED/31931909

Type: Journal Article/Review

Volume: 23

Parent Publication: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease

Issue: 12

ISSN: 1027-3719